Abbott Laboratories, a maker of drugs and other health care products, said yesterday that it has submitted its rheumatoid arthritis drug to regulators in the United States and Europe for approval. The ...

NEW YORK, Jan 17 (Reuters) - New Jersey's attorney general said on Thursday she has subpoenaed Amgen Inc regarding allegations that the biotechnology company promoted its rheumatoid arthritis and ...

CareFirst BlueCross BlueShield accuses Amgen Inc. of monopolizing the prescription drug market for etanercept. Amgen manufactures Enbrel, an injectable form of etanercept for treating rheumatoid ...

Generic drugmaker Sandoz (OTCQX:SDZXF) announced on Monday the filing of an antitrust lawsuit alleging that Amgen (NASDAQ:AMGN) used certain patent-related tactics to extend its U.S. market dominance ...

Negotiations to set prices Medicare will pay for the original branded version of etanercept, Enbrel, should bring the government some genuine savings, and may indirectly make it more affordable for ...

Original Medicare covers most medically necessary treatments for rheumatoid arthritis (RA), including biologics like adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade, Inflectra), and ...

(RTTNews) - Sandoz (SDZNY) has initiated an antitrust lawsuit in the United States against Amgen, Inc. (AMGN), accusing the company of maintaining its dominant market position for the blockbuster drug ...

Sandoz Group AG (OTC:SDZNY) (OTC:SDZXF) on Monday filed an antitrust lawsuit in the U.S. against Amgen, Inc. (NASDAQ:AMGN) for extending and entrenching the dominant market position of its blockbuster ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

DENVER — Colorado became the first state in the country Friday to set a maximum price that insurers and patients can pay for a prescription medication — a move that’s likely to face lawsuits. The ...